4Q67

Staphylococcus aureus F98Y mutant dihydrofolate reductase complexed with NADPH

4Q67 の概要

• エントリーDOI: 10.2210/pdb4q67/pdb
• 関連するPDBエントリー: 4Q6A
• 分子名称: Dihydrofolate reductase, NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE (3 entities in total)
• 機能のキーワード: oxidoreductase
• 由来する生物種: Staphylococcus aureus MUF168
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 19148.43

構造登録者

Reeve, S.M.,Anderson, A.C. (登録日: 2014-04-21, 公開日: 2014-12-31, 最終更新日: 2023-09-20)

主引用文献

Reeve, S.M.,Gainza, P.,Frey, K.M.,Georgiev, I.,Donald, B.R.,Anderson, A.C.
Protein design algorithms predict viable resistance to an experimental antifolate.
Proc.Natl.Acad.Sci.USA, 112:749-754, 2015

PubMed Abstract: Methods to accurately predict potential drug target mutations in response to early-stage leads could drive the design of more resilient first generation drug candidates. In this study, a structure-based protein design algorithm (K* in the OSPREY suite) was used to prospectively identify single-nucleotide polymorphisms that confer resistance to an experimental inhibitor effective against dihydrofolate reductase (DHFR) from Staphylococcus aureus. Four of the top-ranked mutations in DHFR were found to be catalytically competent and resistant to the inhibitor. Selection of resistant bacteria in vitro reveals that two of the predicted mutations arise in the background of a compensatory mutation. Using enzyme kinetics, microbiology, and crystal structures of the complexes, we determined the fitness of the mutant enzymes and strains, the structural basis of resistance, and the compensatory relationship of the mutations. To our knowledge, this work illustrates the first application of protein design algorithms to prospectively predict viable resistance mutations that arise in bacteria under antibiotic pressure.

PubMed: 25552560
DOI: 10.1073/pnas.1411548112

実験手法

X-RAY DIFFRACTION (2.04 Å)